AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Matthew David Morgan

Matthew David Morgan

University of York - York / United Kingdom
Others
AD Scientific Index ID: 1525154
person_outline Matthew David Morgan's MOST POPULAR ARTICLES
1-) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis New England Journal of Medicine 363 (3), 211-220, 2010
2-) 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis Arthritis & Rheumatology 74 (3), 393-399, 2022
3-) Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up Annals of the rheumatic diseases 71 (6), 955-960, 2012
4-) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial Annals of the rheumatic diseases 74 (6), 1178-1182, 2015
5-) Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study American Journal of Kidney Diseases 56 (6), 1082-1094, 2010